WHO certifies five more countries as dracunculiasis-free
6 December 2013 -- The world is getting closer to becoming free from dracunculiasis with the decision by the World Health Organization (WHO) to certify five additional countries - Côte d’Ivoire, Niger and Nigeria Somalia and South Africa.
WHO has certified a total of 197 countries, territories and areas.
One of the largest and longest campaigns to eradicate dracunculiasis has been in Nigeria, which was once the most endemic country worldwide reporting more than 650 000 cases annually.
WHO to roll out implementation strategy to eliminate sleeping sickness
Network to coordinate partner and stakeholder activities being elaborated
15 November 2013 | Geneva – Decline in the number of new cases of sleeping sickness prompts the World Health Organization to roll out the implementation of its elimination strategy in 36 countries in sub-Saharan Africa in early January 2014.
Key elements of the strategy include integrating activities of specialized teams with rural health centres and dispensaries; optimal use of existing tools and widening access to affordable and safe donated medicines.
27 May 2013 | Geneva
Member States call for more focus on the growing threat and spread of dengue
The World Health Assembly today adopted resolution WHA66.12 on all 17 neglected tropical diseases.
Many countries called on WHO to focus more on the growing threat and expansion of dengue and support the scale-up of vector control activities.
Representatives from 32 countries and six speakers from nongovernmental organizations took part in the deliberations.
New phase in fight against NTDs heralds universal access to health interventions for world’s poorest
Sustained commitment key to reaching eradication and elimination targets by 2020
16 January 2013 | Geneva
The World Health Organization’s second report on neglected tropical diseases published today highlights unprecedented progress during the past two years.
Renewed momentum has shifted the world closer to eliminating many of these conditions that take their greatest toll among the poor, thanks to a new global strategy, a regular supply of quality-assured, cost-effective medicines and support from global partners. | More